Cover Image

Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab

<p>Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysiology of macular edema involves both the presence of inflammation and angiogenic stimulant</p><p>regarding vascular endothelial growth factor (VEGF) [1]. Intravitreal injections o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fang-Ting Chen (Author), Jia-Kang Wang (Author)
Format:	Book
Published:	Journal of Clinical Research and Ophthalmology - Peertechz Publications, 2015-02-15.
Subjects:	Editorial
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
by: Messenger WB, et al.
Published: (2013)

Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
by: Stéphanie Baillif, et al.
Published: (2022)

Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
by: A. E. Cheberda, et al.
Published: (2018)

Efficacy and Safety of Fluocinolone Acetonide Implant in Diabetic Macular Edema: Practical Guidelines from Reference Center
by: Lucas Sejournet, et al.
Published: (2024)

Real-World Efficacy and Safety of Fluocinolone Acetonide Implant for Diabetic Macular Edema: A Systematic Review
by: Laurent Kodjikian, et al.
Published: (2021)

Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema
by: Lucy Joanne Kessler, et al.
Published: (2022)

Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study
by: Thibaud Mathis, et al.
Published: (2022)

The Efficacy of Simultaneous Injection of Dexamethasone Implant and Ranibizumab Into Vitreous Cavity on Macular Edema Secondary to Central Retinal Vein Occlusion
by: Xing Du, et al.
Published: (2022)

Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients
by: Dang Y, et al.
Published: (2014)

Widening use of dexamethasone implant for the treatment of macular edema
by: Bonfiglio V, et al.
Published: (2017)

Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective
by: Régnier SA, et al.
Published: (2015)

The role of aflibercept in the management of diabetic macular edema
by: Chang AA, et al.
Published: (2015)

Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
by: Michal Pochopien, et al.
Published: (2019)

Comparative study between ranibizumab and aflibercept in the management of macular edema caused by diabetes mellitus in age group more than 40 years
by: Abd El-Magid M
Published: (2019)

The efficacy and safety of aflibercept and conbercept in diabetic macular edema
by: Cai S, et al.
Published: (2018)

Intravitreal Fluocinolone Acetonide Implant (ILUVIEN®) for the Treatment of Retinal Conditions. A Review of Clinical Studies
by: Mushtaq Y, et al.
Published: (2023)

Pharmacoeconomic analysis of dexamethasone intravitreal implant for the treatment of diabetic macular edema in Russia
by: A. S. Kolbin, et al.
Published: (2018)

Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials
by: Wei Q, et al.
Published: (2019)

Features of aflibercept plus hyperbaric oxygen therapy for diabetic macular edema
by: V. O. Drozdov, et al.
Published: (2022)

Delivery of Intraocular Triamcinolone Acetonide in the Treatment of Macular Edema
by: Brent Siesky, et al.
Published: (2012)

Usefulness of Intravitreal dexamethasone implant in treatment of persistent cystoid macular edema due to Irvine-Gass syndrome
by: Mya Thida Ohn, et al.
Published: (2019)

Efficacy and safety of the dexamethasone implant in vitrectomized and nonvitrectomized eyes with diabetic macular edema: A systematic review and meta-analysis
by: Qiongzhen Yuan, et al.
Published: (2022)

The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions
by: Ciloglu E, et al.
Published: (2019)

Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
by: Jose Navarro-Partida, et al.
Published: (2021)

Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study
by: Ferhat Turgut, et al.
Published: (2024)

Scleral melt following Retisert intravitreal fluocinolone implant
by: Georgalas I, et al.
Published: (2014)

Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
by: Yan PS, et al.
Published: (2016)

Biocompatible lipid nanocarriers for improved skin delivery of fluocinolone acetonide: Physicochemical and in vitro performances
by: Stanković Tijana, et al.
Published: (2023)

Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
by: Tranos P, et al.
Published: (2024)

Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies
by: Claudio Bucolo, et al.
Published: (2018)

Efficacy of single-dose intravitreal dexamethasone implantation for retinal vein occlusion patients with refractory macular edema: A systematic review and meta-analysis
by: Qiongzhen Yuan, et al.
Published: (2022)

Visual Acuity Gain Profiles and Anatomical Prognosis Factors in Patients with Drug-Naive Diabetic Macular Edema Treated with Dexamethasone Implant: The NAVEDEX Study
by: Mauricio Pinto, et al.
Published: (2021)

Budget impact analysis of dexamethasone intravitreal implant for the treatment of diabetic macular oedema
by: Fernando de Andrés-Nogales, et al.
Published: (2018)

Edema macular cistoideo Macular cystoid edema
by: Blanca Nieve Rey Estévez, et al.
Published: (2010)

A Review of the Effectiveness and Side-Effects of Fluocinolone Acetonide 0.1% in the Treatment of Oral Mucosal Diseases
by: Kobkan Thongprasom
Published: (2017)

Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema
by: Hall J
Published: (2016)

Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus
by: Roberta Spinetta, et al.
Published: (2023)

Expert Consensus Optimizing management of patients with visual impairments as a result of diabetic macular edema. Role and place of the anti-VEGF-preparation aflibercept
by: Katz Todd, et al.
Published: (2016)

Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema [Corrigendum]
by: Liu QY, et al.
Published: (2016)

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
by: Dominik Zalewski, et al.
Published: (2014)